Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients

Alessandro Lagana, PhD, Seongjee Park, Donna Edwards, Violetta Leshchenko, PhD, Marsha Crochiere, Yosef Landesman, PhD, David Melnekoff, BS,MS, Itai Beno, PhD, Deepak Perumal, PhD, Deepu Madduri, MD, Joshua Richter, Ajai Chari, MD, Hearn Jay Cho, MD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2018) 132 (Supplement 1): 3216.

https://doi.org/10.1182/blood-2018-99-116500

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Priyanka Pophali, MD, Allison C. Rosenthal, DO, Han Tun, MD, Craig B. Reeder, MD, Ivana N Micallef, MD, Luis Porrata, MD, Stephen M Ansell, MD PhD, Patrick Johnston, MD, David J Inwards, MD

Blood (2017) 130 (Supplement 1): 4536.

https://doi.org/10.1182/blood.V130.Suppl_1.4536.4536

Published: 2017

Journal Articles

Modified Khorana Models for Prediction of Cancer-Associated Venous Thromboembolism: An Exploratory Study

Gabriela Sanchez Petitto, MD, Carmen P Escalante, MD, Marsha N Richardson, MSW, Cristhiam Rojas Hernandez, MD

Blood (2017) 130 (Supplement 1): 4635.

https://doi.org/10.1182/blood.V130.Suppl_1.4635.4635

Published: 2017

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Eiran Warner, MD BA, Catherine Broome, MD

Blood (2016) 128 (22): 3843.

https://doi.org/10.1182/blood.V128.22.3843.3843

Published: 2016

Journal Articles

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Preetesh Jain, MBBS, MDDM, PhD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rashmi Kanagal-Shamanna, MD, Keyur P. Patel, MD PhD, Sara Emogene DellaSala, BS, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan M. O'Brien, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 5436.

https://doi.org/10.1182/blood.V128.22.5436.5436

Published: 2016

Journal Articles

Metastatic prostate cancer mimicking thrombotic thrombocytopenic purpura

Patrick T. Griffin, Michael Jaglal

Blood (2015) 125 (8): 1349.

https://doi.org/10.1182/blood-2014-11-608828

Published: 2015

Journal Articles

Switching to Nilotinib Is Associated with Continued Deeper Molecular Responses in CML-CP Patients with Minimal Residual Disease After ≥ 2 Years On Imatinib: Enestcmr 2-Year Follow-up Results

Timothy P. Hughes, MD, MBBS, Jeffrey H. Lipton, MD, PhD, Nelson Spector, MD, PhD, Brian Leber, MD, Ricardo Pasquini, MD, PhD, Nelma Clementino, MD, Anthony P. Schwarer, MD, Gabriel Etienne, MD, PhD, Agnès Guerci-Bresler, MD, Susan Branford, PhD, Das Purkayastha, LaTonya Collins, BSN, Tomasz Szczudlo, Francisco Cervantes, MD, PhD

Blood (2012) 120 (21): 694.

https://doi.org/10.1182/blood.V120.21.694.694

Published: 2012

Journal Articles

Leukemic and Hematopoietic Stem Cells Compete for the Same Functional Marrow Niche in a MLL-AF9 Murine Leukemia Model

Ronan G. Desmond, MD, MRCP, FRCPath, Taha Bat, Olena Kamenyeva, Benjamin Mizukawa, MD, James C. Mulloy, PhD, Andre Larochelle, MD, PhD, Cynthia E. Dunbar, MD

Blood (2012) 120 (21): 4897.

https://doi.org/10.1182/blood.V120.21.4897.4897

Published: 2012

Journal Articles

Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers.

Javier Loscertales, MD, Eva Arranz, PhD, Maria-Angeles Sanz, PhD, Carmen Burgaleta, MD, PhD, Juan-José Gil-Fernández, MD, PhD, Juan Luis Steegmann, MD, PhD, Adrian Alegre, MD

Blood (2009) 114 (22): 4384.

https://doi.org/10.1182/blood.V114.22.4384.4384

Published: 2009

Journal Articles

Low Toxicity and Mortality with Reversed-Order Conditioning (Cyclophosphamide Followed by Targeted Intravenous Busulfan) in Allogeneic Hematopoietic Cell Transplantation: Preliminary Results of a Prospective Clinical Trial.

Andrew R. Rezvani, MD, Jeannine S. McCune, PhD, Ami Batchelder, Barry E. Storer, PhD, George B. McDonald, MD, H. Joachim Deeg, MD

Blood (2009) 114 (22): 1175.

https://doi.org/10.1182/blood.V114.22.1175.1175

Published: 2009

Journal Articles

Osteonecrosis of the Jaw Related to Bisphosphonates Therapy in Multiple Myeloma and Metastatic Prostate Cancer Patients. A Latin American Report: An Adverse Event To Look For!!.

Brady Beltran, MD, Luis Riva, MD, Daniel del Carpio, MD, Ivan Fernandez, MD, Luis Vera, MD, Rocio Reategui, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo, MD, Antonio A. Carrasco-Yalan, MD

Blood (2007) 110 (11): 5162.

https://doi.org/10.1182/blood.V110.11.5162.5162

Published: 2007

Journal Articles

Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).

Rosetta Martiniello-Wilks, BSc (Hons), PhD, Stephen R. Larsen, MBBS(Hons), Stephane Flamant, BSc (Hons), PhD, Jessamy C. Tiffen, BSc (Hons), Charles G. Bailey, BSc (Hons), PhD, John E.J. Rasko, BSc(Med), MBBS, PhD

Blood (2007) 110 (11): 5148.

https://doi.org/10.1182/blood.V110.11.5148.5148

Published: 2007

Journal Articles

Primary Fibrinolysis as the Presenting Sign of Metastatic Prostate Cancer: One Case Report and Literature Review.

Rongfu Zhou, PhD, Jian Ouyang, MD, Bing Chen, MD, Ming Zhou, MD, Yong Xu, MD, Changgeng Ruan, PhD

Blood (2007) 110 (11): 3966.

https://doi.org/10.1182/blood.V110.11.3966.3966

Published: 2007

Journal Articles

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

Qiuju Wang, MS, Craig Peacock, PhD, Kortney Hensley, Sarah Brennan, Akil Merchant, MD, Evan Jones, Irwin Freed, Richard Ambinder, MD, Karen McGovern, Martin Tremblay, D. Neil Watkins, MD, PhD, William Matsui, MD

Blood (2007) 110 (11): 3582.

https://doi.org/10.1182/blood.V110.11.3582.3582

Published: 2007

Journal Articles

High-Dose Calcitriol Modulates the Expression and Activity of Tissue Factor and Thrombomodulin in Tumor Cells.

Enriqueta Coll-Sangrona, PhD, Ali Amirkhosravi, Ph.D., Alshad S. Lalani, Ph.D., Liza Robles, M.S., Hina Desai, M.S., Mildred Amaya, M.S., John L. Francis, Ph.D.

Blood (2007) 110 (11): 921.

https://doi.org/10.1182/blood.V110.11.921.921

Published: 2007

Journal Articles

Recombinant Activated Factor VII (rFVIIa)-Mediated Normalization of INR Levels Post-Coumadin Overdose.

Wahid T. Hanna, MD

Blood (2005) 106 (11): 4102.

https://doi.org/10.1182/blood.V106.11.4102.4102

Published: 2005

NARROW

E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Modified Khorana Models for Prediction of Cancer-Associated Venous Thromboembolism: An Exploratory Study

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Metastatic prostate cancer mimicking thrombotic thrombocytopenic purpura

Switching to Nilotinib Is Associated with Continued Deeper Molecular Responses in CML-CP Patients with Minimal Residual Disease After ≥ 2 Years On Imatinib: Enestcmr 2-Year Follow-up Results

Leukemic and Hematopoietic Stem Cells Compete for the Same Functional Marrow Niche in a MLL-AF9 Murine Leukemia Model

Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers.

Low Toxicity and Mortality with Reversed-Order Conditioning (Cyclophosphamide Followed by Targeted Intravenous Busulfan) in Allogeneic Hematopoietic Cell Transplantation: Preliminary Results of a Prospective Clinical Trial.

Osteonecrosis of the Jaw Related to Bisphosphonates Therapy in Multiple Myeloma and Metastatic Prostate Cancer Patients. A Latin American Report: An Adverse Event To Look For!!.

Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).

Primary Fibrinolysis as the Presenting Sign of Metastatic Prostate Cancer: One Case Report and Literature Review.

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

High-Dose Calcitriol Modulates the Expression and Activity of Tissue Factor and Thrombomodulin in Tumor Cells.

Recombinant Activated Factor VII (rFVIIa)-Mediated Normalization of INR Levels Post-Coumadin Overdose.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only